Skip to content

Compare medicines

Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.

Attribute
In shortNRTI with a serious HLA-B*5701 hypersensitivity warning.Backbone antiretroviral also active against hepatitis B.
Body systemAntiviralsAntivirals
Drug classNucleos(t)ide reverse transcriptase inhibitorsNucleos(t)ide reverse transcriptase inhibitors
SupplyPrescription onlyWHO essential medicinePrescription onlyWHO essential medicine
Main usesHIV infection (with other drugs)HIV infection (with other drugs), Chronic hepatitis B
How it worksBlocks HIV from copying itself.Blocks HIV and hepatitis B viruses from copying themselves.
Starts workingWeeksWeeks
Half-lifeAbout 1.5 hours (intracellular 12–26 hours)5–7 hours (intracellular 18–22 hours)
Typical adult dose600 mg once a day, or 300 mg twice a day.300 mg once a day or 150 mg twice a day for HIV; 100 mg once a day for hepatitis B.
FormsTablet, Oral solution, Combination tabletsTablet, Oral solution, Fixed-dose combinations
Common side effectsNausea, Headache, Tiredness, DiarrhoeaHeadache, Nausea, Tiredness, Cough
Serious side effectsAbacavir hypersensitivity reaction, Heart attack signal in some studies, Lactic acidosis (rare)Hepatitis flare on stopping in co-infected people, Lactic acidosis (rare), Pancreatitis in children
Don't take ifHLA-B*5701 positive; Previous reaction to abacavir; Moderate to severe liver diseaseTaking emtricitabine (same class)
AlcoholBest to limit. Alcohol raises abacavir levels.Best to limit. Alcohol adds to liver strain, particularly in hepatitis B.
PregnancyGenerally considered safeUsed in pregnancy within HIV regimens.Generally considered safeWidely used in pregnancy within HIV regimens.
BreastfeedingUsually avoidedNot recommended where safe formula is available.Usually avoidedIn high-income countries breastfeeding is not advised with HIV; where formula is unsafe, guidelines support breastfeeding with treatment.
In use since——
Brand namesUnited States: Ziagen, Triumeq (combination)United Kingdom: Ziagen, Kivexa, TriumeqIndia: Abamune, ZiagenUnited States: EpivirUnited Kingdom: EpivirIndia: Lamivir, Lamivudine (generic)
Legal statusUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule HUnited States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H
ATC codeJ05AF06J05AF05

Taken together

No interaction between these medicines is recorded in the atlas.

Open in the interaction checker